Trang chủ › Bạch cầu tủy cấp › Illinois › Chicago
Thử nghiệm lâm sàng cho Bạch cầu tủy cấp tại Chicago, IL
27 nghiên cứu cho Bạch cầu tủy cấp đang tìm kiếm người tham gia tại các cơ sở ở Chicago và vùng lân cận (bán kính khoảng 30 dặm). Mở nghiên cứu để xem tiêu chí tham gia và cách liên hệ với đội ngũ nghiên cứu.
Văn bản nghiên cứu chính thức (Tiếng Anh)
Đang tuyển dụng cho một nghiên cứu? Đưa tin của bạn lên đầu trang này — $99 trong 30 ngày →
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
Đang tuyểnGiai đoạn 2
- Northwestern University, Chicago
- University of Illinois, Chicago
- University of Chicago Comprehensive Cancer Center, Chicago
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
Đang tuyểnGiai đoạn 3
- Northwestern, Chicago
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
Đang tuyểnGiai đoạn 2
- Northwestern University, Chicago
- University of Chicago Comprehensive Cancer Center, Chicago
Bleximenib in Combination With Standard Induction and Consolidation Therapy Followed by Maintenance for Treatment of Patients With Acute Myeloid Leukemia (AML)
Đang tuyểnGiai đoạn 3
- US-Chigago IL-UHCHICAGO, Chicago
Comparing Different Treatment Lengths for Venetoclax in Older People With Newly Diagnosed Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial)
Đang tuyểnGiai đoạn 2
- University of Chicago Comprehensive Cancer Center, Chicago
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Đang tuyểnNghiên cứu quan sátChào đón tình nguyện viên khỏe mạnh
- Mount Sinai Hospital Medical Center, Chicago
- John H Stroger Jr Hospital of Cook County, Chicago
- University of Illinois, Chicago
- và 1 nữa
A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
Đang tuyểnGiai đoạn 3
- University of Chicago Medicine, Chicago
Testing the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 to Improve Outcomes in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes
Đang tuyểnGiai đoạn 1
- University of Chicago Comprehensive Cancer Center, Chicago
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
Đang tuyểnGiai đoạn 2
- Northwestern University, Chicago
- Rush MD Anderson Cancer Center, Chicago
- University of Illinois, Chicago
- và 2 nữa
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
Đang tuyểnGiai đoạn 2
- Northwestern University, Chicago
- University of Chicago Comprehensive Cancer Center, Chicago
Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)
Đang tuyểnGiai đoạn 2
- Northwestern University, Chicago
- University of Illinois, Chicago
- University of Chicago Comprehensive Cancer Center, Chicago
A Study to Assess the Safety, Tolerability, and Antileukemic Activity of Debio 1562M in Participants With Acute Myeloid Leukemia (AML)
Đang tuyểnGiai đoạn 1/2
- University of Chicago, Chicago
A Study to Find the Highest Dose of Cedazuridine and Decitabine Combination With Filgrastim as a Treatment Option After Hematopoietic Stem Cell Transplant in Children With High-Risk Acute Myeloid Leukemia
Đang tuyểnGiai đoạn 1
- Lurie Children's Hospital-Chicago, Chicago
A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
Đang tuyểnGiai đoạn 1/2
- The University of Chicago Medical Center, Chicago
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
Đang tuyểnGiai đoạn 3
- Lurie Children's Hospital-Chicago, Chicago
- University of Illinois, Chicago
- University of Chicago Comprehensive Cancer Center, Chicago
Xylitol Dental Wipes for the Reduction of Bloodstream Infection Risk in Children With Acute Myeloid Leukemia
Đang tuyểnGiai đoạn 3
- Lurie Children's Hospital-Chicago, Chicago
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
Đang tuyểnGiai đoạn 1/2
- Lurie Children's Hospital-Chicago, Chicago
- University of Illinois, Chicago
- University of Chicago Comprehensive Cancer Center, Chicago
A Phase 1b Study of Menin Inhibitor SNDX- 5613 in Combination With Daunorubicin and Cytarabine in Newly Diagnosed Patients With Acute Myeloid Leukemia and NPM1 Mutated/FLT3 Wildtype or MLL/KMT2A Rearranged or NUP98 Alterations Disease
Đang tuyểnGiai đoạn 1
- University of Chicago Comprehensive Cancer Center, Chicago
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
Đang tuyểnGiai đoạn 1
- Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Đang tuyểnNghiên cứu quan sát
- Northwestern Memorial Hospital, Chicago
- Rush University Medical Center, Chicago
- University of Illinois at Chicago, Chicago
- và 2 nữa
Intensity Modulated Total Marrow Irradiation in Fully Human Leukocyte Antigen (HLA)-Matched and Partially-HLA Mismatched Allogeneic Transplantation Patients With High-Risk Acute Myeloid Leukemia (AML), Chronic Myeloid Leukemia (CML), and Myelodysplastic Syndrome (MDS)
Đang tuyểnGiai đoạn 2
- University of Illinois Cancer Center, Chicago
Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.
Đang tuyểnGiai đoạn 1
- University of Chicago, Chicago
A Study of CTX-712 in Relapsed/Refractory Acute Myeloid Leukemia and Higher Risk Myelodysplastic Syndromes
Đang tuyểnGiai đoạn 1/2
- Northwestern University, Chicago
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
Đang tuyểnGiai đoạn 1/2
- Northwestern, Chicago
A Study of CBX-250 in Participants With Relapsed or Refractory Myeloid Leukemias
Đang tuyểnGiai đoạn 1
- Northwestern Medicine, Chicago
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
Đang tuyểnGiai đoạn 1
- Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago
A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrome
Đang tuyểnGiai đoạn 1
- Northwestern Medicine - Northwestern Memorial Hospital Galter Pavilion, Chicago
Thử nghiệm cho Bạch cầu tủy cấp tại các thành phố khác
- Houston, TX88 nghiên cứu
- New York City, NY51 nghiên cứu
- Boston, MA44 nghiên cứu
- Baldwin Park, CA41 nghiên cứu
- Seattle, WA40 nghiên cứu
- Durham, NC34 nghiên cứu
- Columbus, OH34 nghiên cứu
- Philadelphia, PA33 nghiên cứu
- Atlanta, GA30 nghiên cứu
- Tampa, FL30 nghiên cứu
- Los Angeles, CA25 nghiên cứu
- Portland, OR24 nghiên cứu
Các nghiên cứu khác tại Chicago
- Ung thư vú59 nghiên cứu
- Ung thư phổi không tế bào nhỏ59 nghiên cứu
- Ung thư (mọi loại)51 nghiên cứu
- Ung thư tuyến tiền liệt45 nghiên cứu
- Ung thư phổi43 nghiên cứu
- Ung thư di căn42 nghiên cứu
- Béo phì40 nghiên cứu
- Ung thư buồng trứng36 nghiên cứu
- Ung thư đại trực tràng32 nghiên cứu
- Đột quỵ31 nghiên cứu
- Ung thư biểu mô tế bào vảy ở đầu và cổ29 nghiên cứu
- Thừa cân29 nghiên cứu
Nguồn dữ liệu từ ClinicalTrials.gov, cập nhật ngày 15 thg 11, 2026. Mỗi nghiên cứu có tiêu chí riêng; đội ngũ nghiên cứu sẽ quyết định ai đủ điều kiện tham gia.